PFKFB4 was critical for the survival of acute monocytic leukemia (AMoL) cells, serving as a downstream target of MLL through the putative E2F6 binding site in the promoter of the PFKFB4 gene, which might be a potent therapeutic target in AMoL [10]. Here, PFKFB4 is linked to acute monocytic leukemia.